Researchers conducted a systematic review to assess the risk of bias and applicability of prediction models for fear of recurrence in patients with cancer.
SOLVD Health, a privately held company focused on preventing disease through actionable and personalized health information, today announced broad availability of AvertD(R) following FDA approval to ...
This review examines how high-throughput proteomics is expanding precision medicine by improving biomarker discovery, disease ...
Natrx, the company behind Cajun Coral artificial reefs, has developed software to aid in the battle against coastal land loss ...
With a NOK 40 million (approx. €3.5 million) grant, Professor Srdjan Djurovic at the University of Oslo aims to identify early blood-based biomarkers that can predict who is at increased risk of ...
3don MSN
Cheaper sequencing, bigger payoff: New software could bring advanced metagenomics to more labs
Metagenomics relies on the use of software programs called assemblers, which can reconstruct tens of thousands of individual ...
We’re in a perilous moment for water. But the Church Sampler is one of the many devices scientists can use help us make ...
Form: In MLS play, the Loons have won two straight road games, including a 2-1 victory over San Diego on Saturday. Sacramento ...
MBW digs through new patent filings describing a ‘media rights platform’ that sits between rightsholders, gen AI systems, and ...
Can a gut test predict Parkinson's? Research reveals a distinctive gut microbiome signature in at-risk individuals long ...
Can you really predict your baby's gender? From old wives' tales to DNA tests, here's what actually works, and what science ...
Ketamine showed moderate efficacy in super-refractory status epilepticus. Read more about EEG and biomarker response patterns ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results